Etanercept and infliximab associated with cutaneous vasculitis

Open Access
Publisher Website
Google Scholar
Abstract
Sir, Since the addition of tumour necrosis factor (TNF) inhibitors to the armamentarium of drugs used to treat rheumatoid arthritis (RA) in 1998, little has been described in terms of cutaneous vasculitis associated with these medications. We describe a case of cutaneous vasculitis in which symptom onset directly coincided with the institution of TNF inhibitors, and symptom resolution occurred promptly upon drug withdrawal. To our knowledge, this is the first case of cutaneous leucocytoclastic vasculitis occurring with the separate use of etanercept and infliximab in the same patient.

This publication has 0 references indexed in Scilit: